发明名称 Treatment of neurological diseases
摘要 A GIP/GLP1 (Glucose-dependent insulintropic peptide/Glucagon-like peptide 1) co-agonist peptide or derivative for use in the treatment of a neurological disorder. The peptide represented by Formula I: YXEGTFTSDYSIYLDKQAAXEFVXWLLAG-Y1; where X is amino-isobutyric acid and Y1 is absent or at least 8 residues. The neurological disorder may be a neurodegenerative disorder such as Alzheimer's disease, Parkinson's disease and stroke. Also included in the present invention are inter alia pharmaceutical compositions comprising a GIP/GLP1 co-agonist peptide for use in treatment of such disorders, together with methods of treating such disorders as well as other subject matter.
申请公布号 GB2528436(A) 申请公布日期 2016.01.27
申请号 GB20140012578 申请日期 2014.07.15
申请人 LANCASTER UNIVERSITY BUSINESS ENTERPRISES LIMITED 发明人 CHRISTIAN HOLSCHER
分类号 A61K38/26;A61K47/48 主分类号 A61K38/26
代理机构 代理人
主权项
地址
您可能感兴趣的专利